1. Baber NS (2005) Tripartite meeting. Paediatric regulatory guidelines: do they help in optimizing dose selection for children? Brit J Clin Pharmacol 59:6660–6662
2. Bodenheimer T (2000) Uneasy alliance–clinical investigators and the pharmaceutical industry. N Engl J Med 342(20):1539–1544
3. Bücheler R, Schwab M, Mörike K, Kalchthaler B, Mohr H, Schröder H, Schwoerer P, Gleiter CH (2002) Off-label prescribing to outpatient children. Brit Med J 324:1311–1312
4. Commission of the European Communities (2004) Proposal for a Regulation of the European Parliament and the Council on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/83/EC and Regulation (EC) No 726/2004 (presented by the Commission) {SEC(2004) 1144} COM(2004) 599 final 2004/0217 (COD), Brussels, 29.9.2004
5. Commission of the European Communities (2005) Amended proposal for a Regulation of the European Parliament and the Council on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/83/EC and Regulation (EC) No 726/2004 (presented by the Commission pursuant to Article 250 (2) of the EC Treaty), COM(2005) 577 final, 2004/0217 (COD), Brussels, 10.11.2005